Skip to content

Prevalence and Characterization of Persistent Dyspnea After Hospitalization

Prevalence and Characterization of Persistent Dyspnea After an Hospitalization for a Respiratory Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03798158
Acronym
DyHP
Enrollment
150
Registered
2019-01-09
Start date
2019-04-11
Completion date
2025-04-30
Last updated
2021-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea, Pulmonary Disease

Brief summary

The investigators aim to make an overview of persistent dyspnea at the end of an hospitalization for a respiratory disease using an actual tool, the Multidisciplinary Dyspnea Profile questionnaire.

Interventions

OTHERMultidisciplinary Dyspnea Profile questionnaire

Multidisciplinary Dyspnea Profile questionnaire at the beginning and the end of an hospitalization

Sponsors

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years old * Able to respond the questionnaire * Presenting at admission a dyspnea over 3/10 on numerical analogic scale * Admitted for a respiratory cause

Exclusion criteria

* cognitive impairment * aphasia * no french-speaking person

Design outcomes

Primary

MeasureTime frame
Prevalence of persistent dyspnea in the end of an hospitalization for a a respiratory diseaseAn average of one week, until the end of the hospitalization

Secondary

MeasureTime frameDescription
Characterization of persistent dyspnea using MDPAn average of one week, until the end of the hospitalization
Outcome of patients with persistent dyspnea after hospitalization6 months6 months mortality, incidence of rehospitalization

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026